<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01035190</url>
  </required_header>
  <id_info>
    <org_study_id>GAH-F5_2009-223060</org_study_id>
    <nct_id>NCT01035190</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia</brief_title>
  <acronym>NEuroSIS</acronym>
  <official_title>Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Children’s Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Union</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Children’s Hospital Tuebingen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      HYPOTHESIS:

      Early prophylactic inhalation of Budesonide reduces the absolute risk of developing
      bronchopulmonary dysplasia (BPD) or death in preterm infants born &lt;28 weeks gestational age
      (GA) by 10%.

      PRIMARY OBJECTIVE:

      To determine whether inhalation of Budesonide within 12 hours of life improves survival
      without BPD at 36 weeks GA in infants born between 23 and 27 weeks GA.

      SECONDARY OBJECTIVES:

      To determine whether prophylactic inhalation of Budesonide affects neurodevelopment at a
      corrected age of 18-22 months in preterm infants; to determine whether inhalation of
      corticosteroids is associated with adverse treatment effects, alters mortality at 36 weeks
      GA, BPD incidence at 36 weeks GA, and the duration of positive pressure respiratory support
      or supplemental oxygen.

      RATIONALE:

      Pre- and postnatal exposure of the developing lung to inflammation is central to the
      development of BPD and the pulmonary inflammatory response in preterms at risk of developing
      BPD is established very early in life. Corticosteroids have antiinflammatory properties and
      early inhalation of corticosteroids may allow for beneficial local effects on the pulmonary
      system prior to the development of a full inflammatory response with a lower risk of
      undesirable systemic side effects.

      STUDY DESIGN:

      Randomised placebo-controlled, multi-centre clinical trial.

      RESEARCH PLAN:

      Within 2 years 850 infants of 23-27 weeks GA will be randomised during the first 12 hours of
      life to Budesonide or placebo to prevent BPD. Study drugs will be administered via
      Aerochamber and continued until infants are either off supplementary oxygen and positive
      pressure support or have reached a GA of 32 0/7 weeks regardless of ventilatory status. The
      primary outcome of survival without BPD will be determined at 36 weeks GA and BPD will be
      defined according to the physiological definition. Study patients will be followed and
      neurodevelopmental outcomes will be assessed at a corrected age of 18-22 months.

      CLINICAL SIGNIFICANCE:

      BPD not only contributes to the mortality of preterm infants but is also associated with
      impaired neurosensory development in Extremely Low Birth Weight (ELBW) survivors, frequent
      readmission to hospital in the first 2 years of life, as well as with an increased risk of
      asthma, lung function abnormalities and persistent respiratory symptoms in adolescence and
      young adulthood. Systemic corticosteroids are effective in preventing BPD, but their use is
      practically prohibited given their adverse effects on neurodevelopment. Early inhalation of
      corticosteroids has been shown to be associated with secondary pulmonary benefits, but its
      effect on survival without BPD and on neurodevelopment remains unclear.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Survival without BPD at 36 weeks GA</measure>
    <time_frame>36 weeks GA</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neurodevelopment at a corrected age of 18 - 22 months.</measure>
    <time_frame>18 - 22 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">863</enrollment>
  <condition>Bronchopulmonary Dysplasia</condition>
  <arm_group>
    <arm_group_label>inhaled Budesonide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Budesonide</intervention_name>
    <description>Inhalation, 200 µg/puff</description>
    <arm_group_label>inhaled Budesonide</arm_group_label>
    <other_name>Budiair</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  a gestational age of 23 0/7-27 6/7 weeks,

          -  a postnatal age &lt; 12 hours

          -  the necessity for any form of positive pressure support (mechanical or nasal
             ventilation or CPAP

        Exclusion Criteria:

          -  involve a clinical decision not to administer therapies (infant not considered viable)

          -  dysmorphic features or congenital malformations that adversely affect life expectancy
             or neurodevelopment and known or suspected congenital heart disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>12 Hours</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Prof. Dr. med. Dirk Bassler, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Children's Hospital Tuebingen / University Hospital Zurich, Department of Neonatology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Prof. Dr. med. Christian F Poets</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children`s Hospital, Tuebingen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>AZ Sint-Jan Brugge Oostende AV, Department of Neontalogy</name>
      <address>
        <city>Brugge</city>
        <zip>8000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU St-Pierre, UMC St-Pieter</name>
      <address>
        <city>Brussels</city>
        <zip>1000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HUDERF, Department of Neonatology</name>
      <address>
        <city>Bruxelles</city>
        <zip>1020</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Tivoli, Department of Neonatology</name>
      <address>
        <city>La Louvière</city>
        <zip>7100</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Brno, Department of Neonatology</name>
      <address>
        <city>Brno</city>
        <zip>62500</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Ostrava, Department of Neonatology</name>
      <address>
        <city>Ostrava</city>
        <zip>70852</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Plzen, Department of Neonatology</name>
      <address>
        <city>Plzen</city>
        <zip>30599</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charles University, General Faculty Hospital and 1st Faculty of Medicine, Department of Obstetrics and Gynecology</name>
      <address>
        <city>Prague 2</city>
        <zip>12800</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Motol Prague 5, Department of Neonatology</name>
      <address>
        <city>Prague 5</city>
        <zip>15006</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Tomas Bati, Department of Neonatology</name>
      <address>
        <city>Zlin</city>
        <zip>76201</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helsinki University Central Hospital,Hospital for Children and Adolescents, NICU</name>
      <address>
        <city>Helsinki</city>
        <zip>00029</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Kuopio, NICU</name>
      <address>
        <city>Kuopio</city>
        <zip>70211</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oulu University Hospital</name>
      <address>
        <city>Oulu</city>
        <zip>90220</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tampere University Hospita, NICU</name>
      <address>
        <city>Tampere</city>
        <zip>33521</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tartu University Children's Clinic, Paediatric Intensive Care Unit</name>
      <address>
        <city>Tartu</city>
        <zip>50406</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de LilleHôpital Jeanne de Flandres, Pôle de Médecine néonataleUnité de Réanimation néonatale</name>
      <address>
        <city>Lille</city>
        <zip>59035</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Cochin Saint-Vincent de Paul, Dept. of Neonatology</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Clocheville, Service de RéanimationNéonatale</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Children's Hospital Aachen, Dept. of Neonatology</name>
      <address>
        <city>Aachen</city>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Children's Hospital Carl Gustav Carus Dresden, Dept. of Neonatology</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Children`s Hospital Erlangen, Dept. of Neonatology</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Children`s Hospital Essen, Dept. of Pediatrics</name>
      <address>
        <city>Essen</city>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Georg-August University Hospital Goettingen, Dept. of Pediatrics</name>
      <address>
        <city>Goettingen</city>
        <zip>37075</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Hamburg-Eppendorf, Dept. of Neonatology</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children`s Hospital Hannover auf der Bult, Dept. of Neonatology</name>
      <address>
        <city>Hannover</city>
        <zip>30173</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Hannover, Dept. of Neonatology</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Children`s Hospital Heidelberg, Dept. of Neonatology</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Nuernberg Sued, Dept. of Neonatology</name>
      <address>
        <city>Nuernberg</city>
        <zip>90471</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Children´s Hospital Tuebingen, Dept. of Neonatology</name>
      <address>
        <city>Tuebingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ben-Gurion University of NegevSoroka Medical Center, Neonatal Department</name>
      <address>
        <city>Beer Sheva</city>
        <zip>84101</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bnai Zion Medical Center Haifa, Department of Neonatology</name>
      <address>
        <city>Haifa</city>
        <zip>31048</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hadassah Medical Center, Department of Neonatology</name>
      <address>
        <city>Jerusalem</city>
        <zip>96757</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Meir Medical Center, Premature Baby Unit</name>
      <address>
        <city>Kfar-Saba</city>
        <zip>44410</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaplan Medical Center Rehovot, Dept. of Neonatology</name>
      <address>
        <city>Rehovot</city>
        <zip>76100</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Salesi, SOD Neonatologia</name>
      <address>
        <city>Ancona</city>
        <zip>60123</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASO S. Croce e Carie, Terapia Intensiva Neonatale-Neonatologia</name>
      <address>
        <city>Cuneo</city>
        <zip>12100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera di Padova, Dipartimento di Pediatria Salus Pueri</name>
      <address>
        <city>Padova</city>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria Pisana, U.O. Neonatologia</name>
      <address>
        <city>Pisa</city>
        <zip>56100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Sant'Anna, Terapia Intensiva Neonatale Clinica -3°piano</name>
      <address>
        <city>Torino</city>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Erasmus MC - Sophia, Department of Neonatology</name>
      <address>
        <city>Rotterdam</city>
        <zip>3015</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Czech Republic</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Netherlands</country>
  </location_countries>
  <reference>
    <citation>Bassler D, Halliday HL, Plavka R, Hallman M, Shinwell ES, Jarreau PH, Carnielli V, van den Anker J, Schwab M, Poets CF. The Neonatal European Study of Inhaled Steroids (NEUROSIS): an eu-funded international randomised controlled trial in preterm infants. Neonatology. 2010;97(1):52-5. doi: 10.1159/000227294. Epub 2009 Jul 7.</citation>
    <PMID>19590247</PMID>
  </reference>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 17, 2009</study_first_submitted>
  <study_first_submitted_qc>December 17, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 18, 2009</study_first_posted>
  <last_update_submitted>July 4, 2016</last_update_submitted>
  <last_update_submitted_qc>July 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Children’s Hospital Tuebingen</investigator_affiliation>
    <investigator_full_name>Prof. Dr. med. Dirk Bassler, Msc</investigator_full_name>
    <investigator_title>Prof.Dr. med.</investigator_title>
  </responsible_party>
  <keyword>Preterm Infants</keyword>
  <keyword>Inhaled Corticosteroids</keyword>
  <keyword>Bronchopulmonary Dysplasia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperplasia</mesh_term>
    <mesh_term>Bronchopulmonary Dysplasia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Budesonide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

